Inhibitors in childhood hemophilia A: Genetic and treatment-related risk factors for development and eradication-Reference-Cited by-同舟云学术

Inhibitors in childhood hemophilia A: Genetic and treatment-related risk factors for development and eradication

Published:2012-10-25 Issue:S1 Volume:60 Page:S30-S33
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

DiMichele Donna M.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference48 articles.

1. Inhibitor development in haemophilia B: An orphan disease in need of attention;DiMichele;Br J Haematol,2007

2. Assessing risk factors: Prevention of inhibitors in haemophilia;Chambost;Haemophilia,2010

3. The incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom;Hay;Blood,2011

4. In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: A case-control study;Kempton;J Thromb Haemost,2010

5. Malmö International Brother Study Group. The Malmö International Brother Study (MBIS). Genetic defects and inhibitor development in siblings with severe hemophilia A;Astermark;Haematologica,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cell–activating factor modulates the factor VIII immune response in hemophilia A;Journal of Clinical Investigation;2021-04-15

2. Gene therapy for hemophilia: what does the future hold?;Therapeutic Advances in Hematology;2018-08-27

3. Emerging therapies for hemophilia: controversies and unanswered questions;F1000Research;2018-04-24

4. Koagulopathien;Pädiatrische Hämatologie und Onkologie;2018

5. Factor VIII gene variants and inhibitor risk in African American hemophilia A patients;Blood;2015-08-13